In our setting, both C3a and C5a receptors were dramatically up-regulated in the prostate tissue of patients who will develop a prostate cancer, supporting the hypothesis that the two soluble modulators available in situ after the activation of the Complement cascade may play a direct effect on resident cells to promote carcinogenesis. The gene discussed is C3; the disease is Familial prostate cancer.